Skip to main content
Caplight Logo









Veloz Bio

Veloz Bio

Private
MonterreyHealthcare & Life Scienceshttps://www.velozbio.com/

Last Round

Seed

Aug 1, 2023

Total Funding Raised

$4.25M

Company Overview

Veloz Bio is a biotechnology company that develops a rapid protein production system to create sustainable and affordable animal-free proteins using plant metabolism.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Circular Economy, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

molecular farminganimal-free proteincellular agriculturealternative proteinprecision fermentationfood techbiotechnologydairy alternativeegg alternativesustainable ingredientsprotein expressionbioprocessinglab-grown foodcircular economyfood manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veloz Bio Comparables

Compare Veloz Bio with similar companies based on industry and business-model similarity.

Veloz Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kyomei
87%
Finally Foods
84%
Mozza Foods
82%

Veloz Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 1, 2023
AcceleratorApr 26, 2022
AcceleratorJan 14, 2022

Key People

Founding team and executive leadership

Luis Flavio Siller Rodriguez

Cofounder & Chief Operations Officer

Founding Team

Enrique Gonzalez

CEO

Executive Team

Laura Margarita López-Castillo

CTO

Executive Team

Veloz Bio Investors

Notable investors and investment history

Veloz Bio investors
InvestorRounds
Prime CoalitionSeed
Collaborative FundSeed
Redwood Capital PartnersSeed
IndieBioAccelerator
SOSVSeed, Accelerator
Azolla VenturesSeed
Gerber-RauthSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2023

    Raised $4M with participation from Collaborative Fund and SOSV.

  • Apr 26, 2022

    $250K raised with SOSV and IndieBio.

Veloz Bio Filings

Explore SEC and related filing metadata, where available.

Veloz Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Veloz Bio's valuation, stock price, and market status.

Is Veloz Bio a public or private company?

Veloz Bio is a private company.

What is the current stock price of Veloz Bio?

Veloz Bio is a private company with no public stock price. Caplight tracks Veloz Bio's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Veloz Bio worth (valuation)?

Valuation information for Veloz Bio is not publicly available.

Can I buy Veloz Bio stock?

Veloz Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Veloz Bio's last funding round?

Veloz Bio's most recent funding round was Seed on August 1, 2023.

Who are the main investors in Veloz Bio?

Key investors in Veloz Bio include IndieBio.

Will Veloz Bio IPO soon?

No public IPO plans have been announced for Veloz Bio.

How can I track Veloz Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Veloz Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMonterrey
Employee Range13
Year Founded2020
Last FundingAug 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?